

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 5.02447476 |
| 2 | intestinal absorption (GO:0050892) | 4.65139165 |
| 3 | maintenance of gastrointestinal epithelium (GO:0030277) | 4.27580447 |
| 4 | angiotensin maturation (GO:0002003) | 4.25220615 |
| 5 | intestinal cholesterol absorption (GO:0030299) | 4.21518809 |
| 6 | sulfur amino acid catabolic process (GO:0000098) | 4.12111555 |
| 7 | regulation of cholesterol homeostasis (GO:2000188) | 3.85896257 |
| 8 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.79490881 |
| 9 | regulation of cellular extravasation (GO:0002691) | 3.63809929 |
| 10 | alpha-linolenic acid metabolic process (GO:0036109) | 3.56153118 |
| 11 | bile acid and bile salt transport (GO:0015721) | 3.55680383 |
| 12 | cellular response to ethanol (GO:0071361) | 3.53437879 |
| 13 | regulation of vitamin metabolic process (GO:0030656) | 3.38231772 |
| 14 | cellular glucuronidation (GO:0052695) | 3.36223350 |
| 15 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.31793457 |
| 16 | epithelial structure maintenance (GO:0010669) | 3.31530216 |
| 17 | flavonoid metabolic process (GO:0009812) | 3.28258380 |
| 18 | homocysteine metabolic process (GO:0050667) | 3.25893751 |
| 19 | Golgi transport vesicle coating (GO:0048200) | 3.22820012 |
| 20 | COPI coating of Golgi vesicle (GO:0048205) | 3.22820012 |
| 21 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.21151803 |
| 22 | L-fucose catabolic process (GO:0042355) | 3.20946622 |
| 23 | fucose catabolic process (GO:0019317) | 3.20946622 |
| 24 | L-fucose metabolic process (GO:0042354) | 3.20946622 |
| 25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.20350394 |
| 26 | protein carboxylation (GO:0018214) | 3.20350394 |
| 27 | L-phenylalanine catabolic process (GO:0006559) | 3.20063452 |
| 28 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.20063452 |
| 29 | regulation of triglyceride catabolic process (GO:0010896) | 3.19011620 |
| 30 | regulation of guanylate cyclase activity (GO:0031282) | 3.17028781 |
| 31 | negative regulation of cholesterol transport (GO:0032375) | 3.12073964 |
| 32 | negative regulation of sterol transport (GO:0032372) | 3.12073964 |
| 33 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.11777950 |
| 34 | L-phenylalanine metabolic process (GO:0006558) | 3.11777950 |
| 35 | urea cycle (GO:0000050) | 3.11761756 |
| 36 | urea metabolic process (GO:0019627) | 3.11761756 |
| 37 | regulation of bile acid biosynthetic process (GO:0070857) | 3.07457907 |
| 38 | phospholipid homeostasis (GO:0055091) | 2.99925173 |
| 39 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.95349236 |
| 40 | reverse cholesterol transport (GO:0043691) | 2.94800537 |
| 41 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.93360878 |
| 42 | hepatocyte apoptotic process (GO:0097284) | 2.92918991 |
| 43 | * O-glycan processing (GO:0016266) | 2.91180890 |
| 44 | protein-lipid complex assembly (GO:0065005) | 2.89544148 |
| 45 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.88537630 |
| 46 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.88114868 |
| 47 | plasma lipoprotein particle assembly (GO:0034377) | 2.86886287 |
| 48 | sulfate transmembrane transport (GO:1902358) | 2.86115415 |
| 49 | glucuronate metabolic process (GO:0019585) | 2.85959679 |
| 50 | uronic acid metabolic process (GO:0006063) | 2.85959679 |
| 51 | phospholipid efflux (GO:0033700) | 2.85941277 |
| 52 | bile acid metabolic process (GO:0008206) | 2.85282806 |
| 53 | COPII vesicle coating (GO:0048208) | 2.84671484 |
| 54 | high-density lipoprotein particle remodeling (GO:0034375) | 2.84103180 |
| 55 | hormone catabolic process (GO:0042447) | 2.83010411 |
| 56 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.81888025 |
| 57 | negative regulation of fibrinolysis (GO:0051918) | 2.81549017 |
| 58 | transcytosis (GO:0045056) | 2.81545561 |
| 59 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.81462472 |
| 60 | lipoprotein transport (GO:0042953) | 2.80451503 |
| 61 | lipoprotein metabolic process (GO:0042157) | 2.79953637 |
| 62 | cellular response to exogenous dsRNA (GO:0071360) | 2.79754355 |
| 63 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.79678014 |
| 64 | cysteine metabolic process (GO:0006534) | 2.77650908 |
| 65 | digestive system process (GO:0022600) | 2.76712286 |
| 66 | sterol homeostasis (GO:0055092) | 2.74176386 |
| 67 | cholesterol homeostasis (GO:0042632) | 2.73600410 |
| 68 | intestinal epithelial cell development (GO:0060576) | 2.73480389 |
| 69 | hemidesmosome assembly (GO:0031581) | 2.72089174 |
| 70 | regulation of protein activation cascade (GO:2000257) | 2.71135410 |
| 71 | cellular extravasation (GO:0045123) | 2.69896821 |
| 72 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.69804079 |
| 73 | nitrogen cycle metabolic process (GO:0071941) | 2.69636551 |
| 74 | complement activation, alternative pathway (GO:0006957) | 2.68962910 |
| 75 | dendritic cell migration (GO:0036336) | 2.67356703 |
| 76 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.66898021 |
| 77 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.66898021 |
| 78 | exogenous drug catabolic process (GO:0042738) | 2.65234204 |
| 79 | detection of other organism (GO:0098543) | 2.65049911 |
| 80 | aromatic amino acid family catabolic process (GO:0009074) | 2.64849757 |
| 81 | thrombin receptor signaling pathway (GO:0070493) | 2.64355044 |
| 82 | cholesterol efflux (GO:0033344) | 2.64125271 |
| 83 | regulation of complement activation (GO:0030449) | 2.63761125 |
| 84 | drug transport (GO:0015893) | 2.62800613 |
| 85 | growth hormone receptor signaling pathway (GO:0060396) | 2.62168462 |
| 86 | protein retention in ER lumen (GO:0006621) | 2.59377156 |
| 87 | regulation of memory T cell differentiation (GO:0043380) | 2.57732002 |
| 88 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.57714216 |
| 89 | negative regulation of cell killing (GO:0031342) | 2.57714216 |
| 90 | cholesterol transport (GO:0030301) | 2.56726439 |
| 91 | sterol transport (GO:0015918) | 2.56726439 |
| 92 | protein-lipid complex remodeling (GO:0034368) | 2.56617971 |
| 93 | macromolecular complex remodeling (GO:0034367) | 2.56617971 |
| 94 | plasma lipoprotein particle remodeling (GO:0034369) | 2.56617971 |
| 95 | regulation of cholesterol esterification (GO:0010872) | 2.56558817 |
| 96 | virion attachment to host cell (GO:0019062) | 2.56104047 |
| 97 | adhesion of symbiont to host cell (GO:0044650) | 2.56104047 |
| 98 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.55398750 |
| 99 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.52253312 |
| 100 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.51907145 |
| 101 | plasma lipoprotein particle clearance (GO:0034381) | 2.51882427 |
| 102 | positive regulation of lipid catabolic process (GO:0050996) | 2.51586686 |
| 103 | lysine metabolic process (GO:0006553) | 2.49811751 |
| 104 | lysine catabolic process (GO:0006554) | 2.49811751 |
| 105 | positive regulation of antigen processing and presentation (GO:0002579) | 2.49716719 |
| 106 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.48958082 |
| 107 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.48514061 |
| 108 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.48514061 |
| 109 | cell adhesion mediated by integrin (GO:0033627) | 2.47936601 |
| 110 | bile acid biosynthetic process (GO:0006699) | 2.47735778 |
| 111 | positive regulation of respiratory burst (GO:0060267) | 2.47610864 |
| 112 | ethanol metabolic process (GO:0006067) | 2.47269011 |
| 113 | drug transmembrane transport (GO:0006855) | 2.46824307 |
| 114 | mannose metabolic process (GO:0006013) | 2.46216424 |
| 115 | alkaloid metabolic process (GO:0009820) | 2.45574791 |
| 116 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.44631007 |
| 117 | endocrine process (GO:0050886) | 2.44631007 |
| 118 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.44631007 |
| 119 | apoptotic cell clearance (GO:0043277) | 2.44594017 |
| 120 | immunoglobulin mediated immune response (GO:0016064) | 2.44590569 |
| 121 | modulation by symbiont of host defense response (GO:0052031) | 2.44585396 |
| 122 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.44585396 |
| 123 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.44585396 |
| 124 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.44585396 |
| 125 | modulation by symbiont of host immune response (GO:0052553) | 2.44585396 |
| 126 | positive regulation by symbiont of host defense response (GO:0052509) | 2.44585396 |
| 127 | regulation of fibrinolysis (GO:0051917) | 2.43545155 |
| 128 | triglyceride homeostasis (GO:0070328) | 2.43085434 |
| 129 | acylglycerol homeostasis (GO:0055090) | 2.43085434 |
| 130 | hypotonic response (GO:0006971) | 2.42820406 |
| 131 | oligosaccharide biosynthetic process (GO:0009312) | 2.42195575 |
| 132 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.41355600 |
| 133 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.41355600 |
| 134 | regulation of antigen processing and presentation (GO:0002577) | 2.41330101 |
| 135 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.40868301 |
| 136 | glomerular filtration (GO:0003094) | 2.40623945 |
| 137 | epoxygenase P450 pathway (GO:0019373) | 2.39688373 |
| 138 | cellular modified amino acid catabolic process (GO:0042219) | 2.39135132 |
| 139 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.39008157 |
| 140 | production of molecular mediator of immune response (GO:0002440) | 2.38389500 |
| 141 | protein-lipid complex subunit organization (GO:0071825) | 2.38067944 |
| 142 | negative regulation of interleukin-12 production (GO:0032695) | 2.38019983 |
| 143 | ethanol oxidation (GO:0006069) | 2.37942305 |
| 144 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.37654092 |
| 145 | drug catabolic process (GO:0042737) | 2.37486647 |
| 146 | protein autoprocessing (GO:0016540) | 2.37404646 |
| 147 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.37324834 |
| 148 | dendritic cell chemotaxis (GO:0002407) | 2.36411412 |
| 149 | positive regulation of heat generation (GO:0031652) | 2.36172798 |
| 150 | response to hydroperoxide (GO:0033194) | 2.36105508 |
| 151 | regulation of interferon-alpha production (GO:0032647) | 2.35895032 |
| 152 | sulfate transport (GO:0008272) | 2.35639641 |
| 153 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.35170477 |
| 154 | sulfur compound transport (GO:0072348) | 2.35014854 |
| 155 | iron ion import (GO:0097286) | 2.34872185 |
| 156 | positive regulation of fatty acid oxidation (GO:0046321) | 2.34773997 |
| 157 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.34278047 |
| 158 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.34005554 |
| 159 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.33885388 |
| 160 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.33181843 |
| 161 | glycosphingolipid catabolic process (GO:0046479) | 2.32074014 |
| 162 | fucosylation (GO:0036065) | 2.31950137 |
| 163 | peptide catabolic process (GO:0043171) | 2.31171838 |
| 164 | detection of bacterium (GO:0016045) | 2.29797607 |
| 165 | positive regulation of icosanoid secretion (GO:0032305) | 2.29318128 |
| 166 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.27308416 |
| 167 | positive regulation of defense response to virus by host (GO:0002230) | 2.25645084 |
| 168 | positive regulation of interferon-alpha production (GO:0032727) | 2.25041361 |
| 169 | digestion (GO:0007586) | 2.24825431 |
| 170 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.24581114 |
| 171 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.23819873 |
| 172 | renal filtration (GO:0097205) | 2.22724558 |
| 173 | cytidine metabolic process (GO:0046087) | 2.22039058 |
| 174 | cytidine catabolic process (GO:0006216) | 2.22039058 |
| 175 | cytidine deamination (GO:0009972) | 2.22039058 |
| 176 | regulation of icosanoid secretion (GO:0032303) | 2.21554423 |
| 177 | glycolipid catabolic process (GO:0019377) | 2.21207505 |
| 178 | superoxide anion generation (GO:0042554) | 2.18552303 |
| 179 | regulation of gamma-delta T cell activation (GO:0046643) | 2.18032624 |
| 180 | positive regulation of prostaglandin secretion (GO:0032308) | 2.17493440 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.32630728 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.20167628 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.12000887 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.92577957 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.68321163 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.88809137 |
| 7 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.84434741 |
| 8 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.80943037 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.76986919 |
| 10 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.74083721 |
| 11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.73194661 |
| 12 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.57897340 |
| 13 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.52870040 |
| 14 | GATA1_22025678_ChIP-Seq_K562_Human | 2.46533280 |
| 15 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.36540517 |
| 16 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.34937615 |
| 17 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.30193986 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.24639190 |
| 19 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.19606737 |
| 20 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.05910005 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.05098991 |
| 22 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.04819195 |
| 23 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.03013814 |
| 24 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.92680623 |
| 25 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.87104008 |
| 26 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.86679686 |
| 27 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.80107622 |
| 28 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.78300042 |
| 29 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.76750300 |
| 30 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.76686168 |
| 31 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.75237538 |
| 32 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.71238035 |
| 33 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.69215408 |
| 34 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.68371430 |
| 35 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.67572334 |
| 36 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.66783075 |
| 37 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.61466262 |
| 38 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.54963406 |
| 39 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.54930166 |
| 40 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.54696073 |
| 41 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.54648561 |
| 42 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.53868536 |
| 43 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.52780860 |
| 44 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.52275214 |
| 45 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.52274951 |
| 46 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.50599653 |
| 47 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.49323888 |
| 48 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.47074106 |
| 49 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.46855486 |
| 50 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.46571495 |
| 51 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.45541993 |
| 52 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.44683860 |
| 53 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.43686870 |
| 54 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.43686870 |
| 55 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.42215083 |
| 56 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.38390304 |
| 57 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.38206923 |
| 58 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.38002023 |
| 59 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.37770862 |
| 60 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.36778603 |
| 61 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.36645016 |
| 62 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.34196838 |
| 63 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.34152059 |
| 64 | TP53_16413492_ChIP-PET_HCT116_Human | 1.32045097 |
| 65 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.29083389 |
| 66 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.28417678 |
| 67 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.28410796 |
| 68 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.28392865 |
| 69 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.28172466 |
| 70 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27319018 |
| 71 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.27253100 |
| 72 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.26972199 |
| 73 | GATA3_26560356_Chip-Seq_TH2_Human | 1.25015217 |
| 74 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.24971450 |
| 75 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.24957020 |
| 76 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.24373274 |
| 77 | CJUN_26792858_Chip-Seq_BT549_Human | 1.23086272 |
| 78 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.22947019 |
| 79 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.22771210 |
| 80 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.22193913 |
| 81 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.20675912 |
| 82 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.17900351 |
| 83 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.15803071 |
| 84 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.15676179 |
| 85 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.14608038 |
| 86 | GATA2_19941826_ChIP-Seq_K562_Human | 1.14453916 |
| 87 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.14263192 |
| 88 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.14088534 |
| 89 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.11085515 |
| 90 | VDR_22108803_ChIP-Seq_LS180_Human | 1.10982238 |
| 91 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.09725312 |
| 92 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.09709105 |
| 93 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.09694090 |
| 94 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.09398001 |
| 95 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.08981636 |
| 96 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.08846701 |
| 97 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.06912659 |
| 98 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.06459403 |
| 99 | MYB_26560356_Chip-Seq_TH2_Human | 1.06090996 |
| 100 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.05996700 |
| 101 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.05447597 |
| 102 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.05243983 |
| 103 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.03683700 |
| 104 | RXR_22108803_ChIP-Seq_LS180_Human | 1.03600217 |
| 105 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.03576830 |
| 106 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.03281611 |
| 107 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.03143195 |
| 108 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.01195255 |
| 109 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.01043760 |
| 110 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99941646 |
| 111 | ATF3_27146783_Chip-Seq_COLON_Human | 0.98756119 |
| 112 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.98700301 |
| 113 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.98568381 |
| 114 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.98267849 |
| 115 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.98267849 |
| 116 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.97875936 |
| 117 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.97705633 |
| 118 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97447256 |
| 119 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.97187343 |
| 120 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.96337319 |
| 121 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.96240240 |
| 122 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96140280 |
| 123 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.95854607 |
| 124 | GATA1_19941826_ChIP-Seq_K562_Human | 0.94981530 |
| 125 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.94839491 |
| 126 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.94750494 |
| 127 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.94561899 |
| 128 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.93317851 |
| 129 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.92366019 |
| 130 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.92192924 |
| 131 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.92043987 |
| 132 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.91909537 |
| 133 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.91429145 |
| 134 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.91084486 |
| 135 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.90447224 |
| 136 | SPI1_23127762_ChIP-Seq_K562_Human | 0.90191000 |
| 137 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90105301 |
| 138 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.90070297 |
| 139 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.89125527 |
| 140 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.87313388 |
| 141 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.86722351 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 4.27994092 |
| 2 | MP0005365_abnormal_bile_salt | 3.52296188 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 3.44170119 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 3.39074154 |
| 5 | MP0001666_abnormal_nutrient_absorption | 3.15364968 |
| 6 | MP0010234_abnormal_vibrissa_follicle | 3.12794261 |
| 7 | MP0003300_gastrointestinal_ulcer | 3.08320854 |
| 8 | MP0003705_abnormal_hypodermis_morpholog | 2.90729814 |
| 9 | MP0004147_increased_porphyrin_level | 2.90636252 |
| 10 | MP0008004_abnormal_stomach_pH | 2.89313214 |
| 11 | MP0003252_abnormal_bile_duct | 2.87545666 |
| 12 | MP0009785_altered_susceptibility_to | 2.81490498 |
| 13 | MP0006054_spinal_hemorrhage | 2.55124256 |
| 14 | MP0001835_abnormal_antigen_presentation | 2.54977716 |
| 15 | MP0008875_abnormal_xenobiotic_pharmacok | 2.39546925 |
| 16 | MP0001873_stomach_inflammation | 2.35712045 |
| 17 | MP0009840_abnormal_foam_cell | 2.32702607 |
| 18 | MP0008438_abnormal_cutaneous_collagen | 2.09088327 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 2.02210163 |
| 20 | MP0004264_abnormal_extraembryonic_tissu | 2.01617866 |
| 21 | MP0005387_immune_system_phenotype | 1.99864718 |
| 22 | MP0001790_abnormal_immune_system | 1.99864718 |
| 23 | MP0009384_cardiac_valve_regurgitation | 1.99540061 |
| 24 | MP0010329_abnormal_lipoprotein_level | 1.89648954 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 1.82680447 |
| 26 | MP0005025_abnormal_response_to | 1.77830625 |
| 27 | MP0005083_abnormal_biliary_tract | 1.77670077 |
| 28 | MP0010352_gastrointestinal_tract_polyps | 1.76875071 |
| 29 | MP0002876_abnormal_thyroid_physiology | 1.74730965 |
| 30 | MP0003806_abnormal_nucleotide_metabolis | 1.74702541 |
| 31 | MP0010155_abnormal_intestine_physiology | 1.72410872 |
| 32 | MP0005671_abnormal_response_to | 1.70545648 |
| 33 | MP0005000_abnormal_immune_tolerance | 1.64122778 |
| 34 | MP0002452_abnormal_antigen_presenting | 1.56678785 |
| 35 | MP0003868_abnormal_feces_composition | 1.54058602 |
| 36 | MP0005451_abnormal_body_composition | 1.54008816 |
| 37 | MP0000462_abnormal_digestive_system | 1.51181180 |
| 38 | MP0005164_abnormal_response_to | 1.47410941 |
| 39 | MP0002723_abnormal_immune_serum | 1.46886814 |
| 40 | MP0004043_abnormal_pH_regulation | 1.41476396 |
| 41 | MP0000609_abnormal_liver_physiology | 1.39858389 |
| 42 | MP0002254_reproductive_system_inflammat | 1.38157915 |
| 43 | MP0003866_abnormal_defecation | 1.36567200 |
| 44 | MP0002132_abnormal_respiratory_system | 1.36193917 |
| 45 | MP0002060_abnormal_skin_morphology | 1.35970823 |
| 46 | MP0002166_altered_tumor_susceptibility | 1.34235801 |
| 47 | MP0005275_abnormal_skin_tensile | 1.29982191 |
| 48 | MP0003828_pulmonary_edema | 1.29589315 |
| 49 | MP0001663_abnormal_digestive_system | 1.28224725 |
| 50 | MP0001819_abnormal_immune_cell | 1.27747171 |
| 51 | MP0002420_abnormal_adaptive_immunity | 1.26317420 |
| 52 | MP0003566_abnormal_cell_adhesion | 1.24762576 |
| 53 | MP0005220_abnormal_exocrine_pancreas | 1.21663083 |
| 54 | MP0005381_digestive/alimentary_phenotyp | 1.20774254 |
| 55 | MP0000569_abnormal_digit_pigmentation | 1.19097223 |
| 56 | MP0004782_abnormal_surfactant_physiolog | 1.18526751 |
| 57 | MP0000465_gastrointestinal_hemorrhage | 1.17905531 |
| 58 | MP0000477_abnormal_intestine_morphology | 1.17640425 |
| 59 | MP0004947_skin_inflammation | 1.16030735 |
| 60 | MP0001664_abnormal_digestion | 1.15533993 |
| 61 | MP0004883_abnormal_blood_vessel | 1.15254693 |
| 62 | MP0009643_abnormal_urine_homeostasis | 1.14993606 |
| 63 | MP0001765_abnormal_ion_homeostasis | 1.13896771 |
| 64 | MP0005058_abnormal_lysosome_morphology | 1.13580530 |
| 65 | MP0003453_abnormal_keratinocyte_physiol | 1.13157796 |
| 66 | MP0010678_abnormal_skin_adnexa | 1.12812291 |
| 67 | MP0005332_abnormal_amino_acid | 1.11990809 |
| 68 | MP0002118_abnormal_lipid_homeostasis | 1.10733306 |
| 69 | MP0005023_abnormal_wound_healing | 1.10473495 |
| 70 | MP0002277_abnormal_respiratory_mucosa | 1.10304114 |
| 71 | MP0002877_abnormal_melanocyte_morpholog | 1.10298497 |
| 72 | MP0002138_abnormal_hepatobiliary_system | 1.09503398 |
| 73 | MP0004019_abnormal_vitamin_homeostasis | 1.08205506 |
| 74 | MP0000383_abnormal_hair_follicle | 1.01143442 |
| 75 | MP0005310_abnormal_salivary_gland | 1.00750697 |
| 76 | MP0002405_respiratory_system_inflammati | 0.99005523 |
| 77 | MP0000490_abnormal_crypts_of | 0.98633879 |
| 78 | MP0004185_abnormal_adipocyte_glucose | 0.94636468 |
| 79 | MP0005167_abnormal_blood-brain_barrier | 0.93270989 |
| 80 | MP0002998_abnormal_bone_remodeling | 0.93073604 |
| 81 | MP0005076_abnormal_cell_differentiation | 0.93055513 |
| 82 | MP0000470_abnormal_stomach_morphology | 0.92281740 |
| 83 | MP0003045_fibrosis | 0.91724548 |
| 84 | MP0005319_abnormal_enzyme/_coenzyme | 0.91703145 |
| 85 | MP0005636_abnormal_mineral_homeostasis | 0.91036301 |
| 86 | MP0010368_abnormal_lymphatic_system | 0.90673291 |
| 87 | MP0003195_calcinosis | 0.90356422 |
| 88 | MP0003724_increased_susceptibility_to | 0.87293507 |
| 89 | MP0000858_altered_metastatic_potential | 0.87032960 |
| 90 | MP0005397_hematopoietic_system_phenotyp | 0.85616309 |
| 91 | MP0001545_abnormal_hematopoietic_system | 0.85616309 |
| 92 | MP0003011_delayed_dark_adaptation | 0.85540360 |
| 93 | MP0001845_abnormal_inflammatory_respons | 0.85302014 |
| 94 | MP0005084_abnormal_gallbladder_morpholo | 0.85256864 |
| 95 | MP0004272_abnormal_basement_membrane | 0.84871033 |
| 96 | MP0001849_ear_inflammation | 0.83599091 |
| 97 | MP0008872_abnormal_physiological_respon | 0.83515423 |
| 98 | MP0001243_abnormal_dermal_layer | 0.82711091 |
| 99 | MP0003950_abnormal_plasma_membrane | 0.81638010 |
| 100 | MP0000716_abnormal_immune_system | 0.81404858 |
| 101 | MP0002009_preneoplasia | 0.81240221 |
| 102 | MP0002933_joint_inflammation | 0.80878319 |
| 103 | MP0002896_abnormal_bone_mineralization | 0.80532623 |
| 104 | MP0001216_abnormal_epidermal_layer | 0.79727461 |
| 105 | MP0001879_abnormal_lymphatic_vessel | 0.79526995 |
| 106 | MP0000598_abnormal_liver_morphology | 0.79524280 |
| 107 | MP0000377_abnormal_hair_follicle | 0.79415574 |
| 108 | MP0003656_abnormal_erythrocyte_physiolo | 0.78515009 |
| 109 | MP0005390_skeleton_phenotype | 0.78448748 |
| 110 | MP0005464_abnormal_platelet_physiology | 0.78092812 |
| 111 | MP0003091_abnormal_cell_migration | 0.77869656 |
| 112 | MP0002796_impaired_skin_barrier | 0.76080613 |
| 113 | MP0002006_tumorigenesis | 0.75968472 |
| 114 | MP0000427_abnormal_hair_cycle | 0.75696346 |
| 115 | MP0001533_abnormal_skeleton_physiology | 0.75543234 |
| 116 | MP0003436_decreased_susceptibility_to | 0.74491874 |
| 117 | MP0000685_abnormal_immune_system | 0.73277751 |
| 118 | MP0009278_abnormal_bone_marrow | 0.73097586 |
| 119 | MP0008469_abnormal_protein_level | 0.73020891 |
| 120 | MP0001881_abnormal_mammary_gland | 0.72626776 |
| 121 | MP0000538_abnormal_urinary_bladder | 0.72123628 |
| 122 | MP0003279_aneurysm | 0.71913651 |
| 123 | MP0009764_decreased_sensitivity_to | 0.70386518 |
| 124 | MP0003303_peritoneal_inflammation | 0.70313515 |
| 125 | MP0006082_CNS_inflammation | 0.69574020 |
| 126 | MP0005166_decreased_susceptibility_to | 0.68801472 |
| 127 | MP0005408_hypopigmentation | 0.68263862 |
| 128 | MP0001958_emphysema | 0.67632164 |
| 129 | MP0003183_abnormal_peptide_metabolism | 0.67451279 |
| 130 | MP0002136_abnormal_kidney_physiology | 0.65985182 |
| 131 | MP0000767_abnormal_smooth_muscle | 0.65462838 |
| 132 | MP0000537_abnormal_urethra_morphology | 0.65404733 |
| 133 | MP0002168_other_aberrant_phenotype | 0.63884555 |
| 134 | MP0005165_increased_susceptibility_to | 0.63810418 |
| 135 | MP0005666_abnormal_adipose_tissue | 0.62008943 |
| 136 | MP0000003_abnormal_adipose_tissue | 0.61707090 |
| 137 | MP0009053_abnormal_anal_canal | 0.60633974 |
| 138 | MP0002419_abnormal_innate_immunity | 0.59443838 |
| 139 | MP0000249_abnormal_blood_vessel | 0.59064021 |
| 140 | MP0001800_abnormal_humoral_immune | 0.58115565 |
| 141 | MP0002928_abnormal_bile_duct | 0.57883953 |
| 142 | MP0002098_abnormal_vibrissa_morphology | 0.57690069 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 4.18118551 |
| 2 | Abnormality of B cell number (HP:0010975) | 4.15971673 |
| 3 | Hyperactive renin-angiotensin system (HP:0000841) | 3.66332546 |
| 4 | Deep venous thrombosis (HP:0002625) | 3.62909859 |
| 5 | B lymphocytopenia (HP:0010976) | 3.62000511 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.59508778 |
| 7 | Ileus (HP:0002595) | 3.57999606 |
| 8 | Xanthomatosis (HP:0000991) | 3.55083233 |
| 9 | Orchitis (HP:0100796) | 3.50488543 |
| 10 | Right ventricular cardiomyopathy (HP:0011663) | 3.44494639 |
| 11 | Abnormality of T cell number (HP:0011839) | 3.44434759 |
| 12 | Myositis (HP:0100614) | 3.42912551 |
| 13 | Aortic aneurysm (HP:0004942) | 3.42760160 |
| 14 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.38051718 |
| 15 | Retrobulbar optic neuritis (HP:0100654) | 3.36903686 |
| 16 | Optic neuritis (HP:0100653) | 3.36903686 |
| 17 | T lymphocytopenia (HP:0005403) | 3.35022679 |
| 18 | Thyroiditis (HP:0100646) | 3.32119498 |
| 19 | Fat malabsorption (HP:0002630) | 3.26028968 |
| 20 | Decreased circulating renin level (HP:0003351) | 3.18332865 |
| 21 | Metabolic alkalosis (HP:0200114) | 3.12754227 |
| 22 | Aortic dissection (HP:0002647) | 3.11012863 |
| 23 | Conjugated hyperbilirubinemia (HP:0002908) | 3.07699108 |
| 24 | Eosinophilia (HP:0001880) | 3.06629912 |
| 25 | Hypoplasia of the thymus (HP:0000778) | 3.01282952 |
| 26 | Hypobetalipoproteinemia (HP:0003563) | 2.98320006 |
| 27 | Hypoproteinemia (HP:0003075) | 2.97823376 |
| 28 | Complement deficiency (HP:0004431) | 2.97687274 |
| 29 | Eczematoid dermatitis (HP:0000976) | 2.92024087 |
| 30 | Hypoglycemic coma (HP:0001325) | 2.91066392 |
| 31 | Chronic sinusitis (HP:0011109) | 2.90660747 |
| 32 | Biliary tract neoplasm (HP:0100574) | 2.89520656 |
| 33 | Pigmentary retinal degeneration (HP:0001146) | 2.88841995 |
| 34 | Abnormality of the common coagulation pathway (HP:0010990) | 2.82676378 |
| 35 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.82507861 |
| 36 | Myocardial infarction (HP:0001658) | 2.81891564 |
| 37 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.81844428 |
| 38 | Protrusio acetabuli (HP:0003179) | 2.72779506 |
| 39 | Panhypogammaglobulinemia (HP:0003139) | 2.72394987 |
| 40 | Recurrent bronchitis (HP:0002837) | 2.69165265 |
| 41 | Recurrent fungal infections (HP:0002841) | 2.61729344 |
| 42 | Severe combined immunodeficiency (HP:0004430) | 2.61702938 |
| 43 | Congenital sensorineural hearing impairment (HP:0008527) | 2.61628089 |
| 44 | Abnormality of eosinophils (HP:0001879) | 2.60112690 |
| 45 | Atrophic scars (HP:0001075) | 2.59951790 |
| 46 | Abdominal distention (HP:0003270) | 2.59128236 |
| 47 | Hypolipoproteinemia (HP:0010981) | 2.53062914 |
| 48 | Hematochezia (HP:0002573) | 2.52710138 |
| 49 | Abnormal biliary tract morphology (HP:0012440) | 2.50692381 |
| 50 | Stomatitis (HP:0010280) | 2.47810307 |
| 51 | Cerebral aneurysm (HP:0004944) | 2.47529318 |
| 52 | Recurrent abscess formation (HP:0002722) | 2.45063323 |
| 53 | Alkalosis (HP:0001948) | 2.44997434 |
| 54 | Recurrent bacterial skin infections (HP:0005406) | 2.44923948 |
| 55 | Esophageal varix (HP:0002040) | 2.44432742 |
| 56 | Abnormality of renin-angiotensin system (HP:0000847) | 2.44085905 |
| 57 | Meningitis (HP:0001287) | 2.44037309 |
| 58 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.42671227 |
| 59 | Abnormality of the intrinsic pathway (HP:0010989) | 2.42300478 |
| 60 | Rectal prolapse (HP:0002035) | 2.41961874 |
| 61 | Leukocytosis (HP:0001974) | 2.41526005 |
| 62 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.41152355 |
| 63 | Absent/shortened dynein arms (HP:0200106) | 2.41152355 |
| 64 | Pulmonary infiltrates (HP:0002113) | 2.40940914 |
| 65 | Abnormality of complement system (HP:0005339) | 2.39452505 |
| 66 | Granulocytopenia (HP:0001913) | 2.38786934 |
| 67 | Premature rupture of membranes (HP:0001788) | 2.37752238 |
| 68 | Stomach cancer (HP:0012126) | 2.35916095 |
| 69 | Abnormality of chloride homeostasis (HP:0011422) | 2.34932425 |
| 70 | Gastrointestinal infarctions (HP:0005244) | 2.34417799 |
| 71 | Hypoalphalipoproteinemia (HP:0003233) | 2.32479237 |
| 72 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.30619422 |
| 73 | Chorioretinal atrophy (HP:0000533) | 2.30509862 |
| 74 | Abnormality of macrophages (HP:0004311) | 2.29317528 |
| 75 | Osteolytic defects of the hand bones (HP:0009699) | 2.29170289 |
| 76 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.29170289 |
| 77 | Keratoconjunctivitis sicca (HP:0001097) | 2.27358680 |
| 78 | Vasculitis (HP:0002633) | 2.25931543 |
| 79 | Hemoptysis (HP:0002105) | 2.24735313 |
| 80 | Abnormality of T cells (HP:0002843) | 2.23681056 |
| 81 | Cone-rod dystrophy (HP:0000548) | 2.23512140 |
| 82 | Arterial tortuosity (HP:0005116) | 2.22563311 |
| 83 | Cervical subluxation (HP:0003308) | 2.22433054 |
| 84 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.22125610 |
| 85 | Mucopolysacchariduria (HP:0008155) | 2.22125610 |
| 86 | Agammaglobulinemia (HP:0004432) | 2.21996081 |
| 87 | Mitral valve prolapse (HP:0001634) | 2.21612144 |
| 88 | Chronic diarrhea (HP:0002028) | 2.21265697 |
| 89 | Systemic lupus erythematosus (HP:0002725) | 2.20124165 |
| 90 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.17620724 |
| 91 | Hypercholesterolemia (HP:0003124) | 2.16195674 |
| 92 | Prolonged partial thromboplastin time (HP:0003645) | 2.15625175 |
| 93 | Malnutrition (HP:0004395) | 2.14761804 |
| 94 | Hypoglycemic seizures (HP:0002173) | 2.14657327 |
| 95 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.14100110 |
| 96 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.13321576 |
| 97 | Aneurysm (HP:0002617) | 2.12943781 |
| 98 | Epidermoid cyst (HP:0200040) | 2.12782947 |
| 99 | Autoimmune hemolytic anemia (HP:0001890) | 2.12208392 |
| 100 | Peritonitis (HP:0002586) | 2.10425843 |
| 101 | Bronchitis (HP:0012387) | 2.10261152 |
| 102 | Vacuolated lymphocytes (HP:0001922) | 2.10259011 |
| 103 | Neoplasm of the rectum (HP:0100743) | 2.10258263 |
| 104 | Hyperlipoproteinemia (HP:0010980) | 2.10147570 |
| 105 | Recurrent viral infections (HP:0004429) | 2.09485968 |
| 106 | Chronic otitis media (HP:0000389) | 2.08137258 |
| 107 | Keratoconjunctivitis (HP:0001096) | 2.07629256 |
| 108 | Steatorrhea (HP:0002570) | 2.06848169 |
| 109 | Vascular tortuosity (HP:0004948) | 2.06257025 |
| 110 | Flat acetabular roof (HP:0003180) | 2.05810107 |
| 111 | Broad metatarsal (HP:0001783) | 2.05568711 |
| 112 | Amyloidosis (HP:0011034) | 2.04818730 |
| 113 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.04516738 |
| 114 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.04516738 |
| 115 | Hyperglycemia (HP:0003074) | 2.03792854 |
| 116 | Hyperammonemia (HP:0001987) | 2.03027636 |
| 117 | Gingivitis (HP:0000230) | 2.02967349 |
| 118 | Agnosia (HP:0010524) | 2.01873453 |
| 119 | Dysostosis multiplex (HP:0000943) | 2.01006788 |
| 120 | Abnormality of the nasal mucosa (HP:0000433) | 1.99091840 |
| 121 | Combined immunodeficiency (HP:0005387) | 1.98931847 |
| 122 | Fragile skin (HP:0001030) | 1.97933088 |
| 123 | Abnormality of purine metabolism (HP:0004352) | 1.97549971 |
| 124 | Rhinitis (HP:0012384) | 1.97366163 |
| 125 | Hepatocellular carcinoma (HP:0001402) | 1.97102374 |
| 126 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.96780327 |
| 127 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.96780327 |
| 128 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.96780327 |
| 129 | Cardiovascular calcification (HP:0011915) | 1.96574723 |
| 130 | Hydroxyprolinuria (HP:0003080) | 1.96217345 |
| 131 | Abnormality of proline metabolism (HP:0010907) | 1.96217345 |
| 132 | Subacute progressive viral hepatitis (HP:0006572) | 1.96170997 |
| 133 | Encephalitis (HP:0002383) | 1.95810193 |
| 134 | Ketosis (HP:0001946) | 1.94833437 |
| 135 | Osteomyelitis (HP:0002754) | 1.93809960 |
| 136 | Milia (HP:0001056) | 1.93754513 |
| 137 | Abnormal ciliary motility (HP:0012262) | 1.92223271 |
| 138 | Mediastinal lymphadenopathy (HP:0100721) | 1.91621681 |
| 139 | Abnormal foot bone ossification (HP:0010675) | 1.91116044 |
| 140 | Abnormality of vitamin B metabolism (HP:0004340) | 1.90449508 |
| 141 | Ankle contracture (HP:0006466) | 1.90334775 |
| 142 | Nasal polyposis (HP:0100582) | 1.88834431 |
| 143 | Acanthocytosis (HP:0001927) | 1.88590974 |
| 144 | Pustule (HP:0200039) | 1.88323903 |
| 145 | Periodontitis (HP:0000704) | 1.87954682 |
| 146 | Disproportionate tall stature (HP:0001519) | 1.87672612 |
| 147 | Skin rash (HP:0000988) | 1.87611666 |
| 148 | Recurrent sinusitis (HP:0011108) | 1.87418808 |
| 149 | Curly hair (HP:0002212) | 1.86461770 |
| 150 | Autoimmune thrombocytopenia (HP:0001973) | 1.86095253 |
| 151 | Dilatation of the ascending aorta (HP:0005111) | 1.85290090 |
| 152 | Late onset (HP:0003584) | 1.84946183 |
| 153 | Symptomatic seizures (HP:0011145) | 1.84284978 |
| 154 | Glomerulonephritis (HP:0000099) | 1.83554598 |
| 155 | Hyperaldosteronism (HP:0000859) | 1.83126429 |
| 156 | IgG deficiency (HP:0004315) | 1.82676278 |
| 157 | Recurrent pneumonia (HP:0006532) | 1.82572286 |
| 158 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.82526687 |
| 159 | Abnormal cartilage morphology (HP:0002763) | 1.82301321 |
| 160 | Bronchiectasis (HP:0002110) | 1.81878015 |
| 161 | Enlarged epiphyses (HP:0010580) | 1.81641231 |
| 162 | Spontaneous hematomas (HP:0007420) | 1.80524931 |
| 163 | Ketoacidosis (HP:0001993) | 1.79970402 |
| 164 | Mitral stenosis (HP:0001718) | 1.79537024 |
| 165 | Vascular calcification (HP:0004934) | 1.79221043 |
| 166 | Decreased central vision (HP:0007663) | 1.79172432 |
| 167 | Widely patent fontanelles and sutures (HP:0004492) | 1.79144580 |
| 168 | Abnormal tarsal ossification (HP:0008369) | 1.76773400 |
| 169 | Skin nodule (HP:0200036) | 1.76220428 |
| 170 | Spondylolisthesis (HP:0003302) | 1.75996362 |
| 171 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.75300145 |
| 172 | Polycythemia (HP:0001901) | 1.73697505 |
| 173 | Thin bony cortex (HP:0002753) | 1.73361468 |
| 174 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.72834801 |
| 175 | Protuberant abdomen (HP:0001538) | 1.72537616 |
| 176 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.71552304 |
| 177 | Gastrointestinal dysmotility (HP:0002579) | 1.70859122 |
| 178 | Ectopia lentis (HP:0001083) | 1.70136809 |
| 179 | Interstitial pulmonary disease (HP:0006530) | 1.69839208 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 4.33534728 |
| 2 | FRK | 4.12484713 |
| 3 | ERN1 | 3.55776225 |
| 4 | LMTK2 | 2.92145717 |
| 5 | BMPR2 | 2.55586347 |
| 6 | MST1R | 2.54541926 |
| 7 | TRIB3 | 2.52627500 |
| 8 | SIK1 | 2.51033515 |
| 9 | PTK6 | 2.46054563 |
| 10 | TGFBR2 | 2.44945297 |
| 11 | PKN2 | 2.32323621 |
| 12 | MAP3K10 | 2.25853591 |
| 13 | MST4 | 2.25321515 |
| 14 | OXSR1 | 2.11188067 |
| 15 | EPHB1 | 2.09879557 |
| 16 | LATS1 | 2.02411671 |
| 17 | FGFR4 | 1.98341789 |
| 18 | PDK2 | 1.97134840 |
| 19 | STK10 | 1.83120493 |
| 20 | TAOK3 | 1.77905781 |
| 21 | RIPK4 | 1.69022799 |
| 22 | RIPK1 | 1.64029912 |
| 23 | BCKDK | 1.54984887 |
| 24 | MET | 1.53234379 |
| 25 | NUAK1 | 1.52671875 |
| 26 | LRRK2 | 1.44235113 |
| 27 | TXK | 1.42168928 |
| 28 | MATK | 1.42059238 |
| 29 | EPHA3 | 1.39145723 |
| 30 | ERBB4 | 1.39036981 |
| 31 | PIK3CG | 1.38857483 |
| 32 | PRKG2 | 1.38123582 |
| 33 | TYK2 | 1.37104678 |
| 34 | STK24 | 1.37023271 |
| 35 | INSRR | 1.36958518 |
| 36 | BLK | 1.30743737 |
| 37 | EEF2K | 1.30245025 |
| 38 | MAPKAPK3 | 1.29907265 |
| 39 | TTN | 1.29335943 |
| 40 | ADRBK2 | 1.29283935 |
| 41 | KIT | 1.27367327 |
| 42 | FLT3 | 1.26876933 |
| 43 | MAP2K2 | 1.26289220 |
| 44 | IRAK1 | 1.25028616 |
| 45 | NEK9 | 1.22392495 |
| 46 | PIK3CA | 1.21747667 |
| 47 | IKBKB | 1.20053688 |
| 48 | CDK6 | 1.16135440 |
| 49 | MAP4K1 | 1.14184290 |
| 50 | JAK1 | 1.13811325 |
| 51 | TEC | 1.13751362 |
| 52 | BMPR1B | 1.13502735 |
| 53 | PDGFRA | 1.09427934 |
| 54 | WNK4 | 1.06093095 |
| 55 | DYRK1B | 1.04708064 |
| 56 | FGFR3 | 1.04594148 |
| 57 | EIF2AK3 | 1.03471988 |
| 58 | PTK2 | 1.03020426 |
| 59 | ITK | 1.02637412 |
| 60 | MAPK15 | 1.00653896 |
| 61 | MAP3K2 | 0.99729301 |
| 62 | TLK1 | 0.98614451 |
| 63 | SYK | 0.95850748 |
| 64 | MAP3K3 | 0.95804866 |
| 65 | IRAK4 | 0.95772004 |
| 66 | TGFBR1 | 0.95124429 |
| 67 | IRAK3 | 0.94989288 |
| 68 | GRK6 | 0.94657922 |
| 69 | STK3 | 0.92542632 |
| 70 | GRK1 | 0.91023192 |
| 71 | TBK1 | 0.90931293 |
| 72 | DDR2 | 0.90665434 |
| 73 | PAK4 | 0.90235932 |
| 74 | PDGFRB | 0.90204282 |
| 75 | CAMK1D | 0.89131568 |
| 76 | SCYL2 | 0.88596418 |
| 77 | ZAP70 | 0.88256817 |
| 78 | CAMKK2 | 0.87008421 |
| 79 | CSK | 0.85304060 |
| 80 | RPS6KA4 | 0.83535289 |
| 81 | DMPK | 0.82118151 |
| 82 | MAP3K12 | 0.81493815 |
| 83 | CDK9 | 0.81306991 |
| 84 | FGFR2 | 0.80289666 |
| 85 | ERBB2 | 0.79944508 |
| 86 | PRKAA2 | 0.79635723 |
| 87 | ERBB3 | 0.78475876 |
| 88 | LCK | 0.78354692 |
| 89 | CSF1R | 0.78348293 |
| 90 | PAK2 | 0.78329475 |
| 91 | GRK7 | 0.78288579 |
| 92 | KDR | 0.78265819 |
| 93 | MAPK11 | 0.77986917 |
| 94 | ADRBK1 | 0.77073365 |
| 95 | MAP3K7 | 0.77031626 |
| 96 | FER | 0.76315779 |
| 97 | LYN | 0.75364525 |
| 98 | BMX | 0.71905492 |
| 99 | MAP3K13 | 0.70123266 |
| 100 | YES1 | 0.70096007 |
| 101 | WNK1 | 0.69842836 |
| 102 | JAK2 | 0.69331808 |
| 103 | HCK | 0.66763857 |
| 104 | MYLK | 0.65765067 |
| 105 | GSK3A | 0.64445837 |
| 106 | MAP3K14 | 0.59726394 |
| 107 | PRKCQ | 0.59706606 |
| 108 | IKBKE | 0.57975793 |
| 109 | JAK3 | 0.57446524 |
| 110 | BRSK2 | 0.56476843 |
| 111 | EPHB2 | 0.55948774 |
| 112 | TESK1 | 0.55497998 |
| 113 | EPHA2 | 0.54751151 |
| 114 | MAP2K1 | 0.53565057 |
| 115 | MAP3K8 | 0.51122465 |
| 116 | HIPK2 | 0.50701429 |
| 117 | MTOR | 0.48381166 |
| 118 | MAP3K1 | 0.47698113 |
| 119 | CHUK | 0.47641581 |
| 120 | BTK | 0.46202551 |
| 121 | MAP2K3 | 0.44734821 |
| 122 | IGF1R | 0.43566346 |
| 123 | PIM1 | 0.42848703 |
| 124 | PRKD1 | 0.41462899 |
| 125 | FGFR1 | 0.41404962 |
| 126 | ABL2 | 0.41269501 |
| 127 | NLK | 0.40635447 |
| 128 | STK39 | 0.39912528 |
| 129 | PRKCE | 0.39654478 |
| 130 | MAP4K2 | 0.38717370 |
| 131 | RET | 0.38564908 |
| 132 | TRPM7 | 0.37872243 |
| 133 | TIE1 | 0.37477320 |
| 134 | MARK3 | 0.36824366 |
| 135 | EGFR | 0.35597021 |
| 136 | MAPKAPK2 | 0.35245092 |
| 137 | TESK2 | 0.34402568 |
| 138 | PRKAA1 | 0.34357396 |
| 139 | MAP3K6 | 0.34128779 |
| 140 | PRKCD | 0.33399089 |
| 141 | PDK1 | 0.32990730 |
| 142 | MELK | 0.31204145 |
| 143 | INSR | 0.31025029 |
| 144 | PDPK1 | 0.30943500 |
| 145 | ABL1 | 0.30603307 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.50967930 |
| 2 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.17511545 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.11274364 |
| 4 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.44745668 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.28095507 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.19825527 |
| 7 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.13136253 |
| 8 | Histidine metabolism_Homo sapiens_hsa00340 | 2.03206381 |
| 9 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.01069182 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.00953759 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.99244847 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.91400974 |
| 13 | Asthma_Homo sapiens_hsa05310 | 1.85728793 |
| 14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.80103220 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.79765774 |
| 16 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.74077597 |
| 17 | Bile secretion_Homo sapiens_hsa04976 | 1.73471758 |
| 18 | Allograft rejection_Homo sapiens_hsa05330 | 1.69519775 |
| 19 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.67895576 |
| 20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.66576461 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.59659557 |
| 22 | * Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.57350539 |
| 23 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.56238795 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.51021234 |
| 25 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.50578979 |
| 26 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.49424967 |
| 27 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.42954160 |
| 28 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.40444733 |
| 29 | ABC transporters_Homo sapiens_hsa02010 | 1.36108107 |
| 30 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.35048547 |
| 31 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.34287439 |
| 32 | Mineral absorption_Homo sapiens_hsa04978 | 1.32933184 |
| 33 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.32515258 |
| 34 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.28665075 |
| 35 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.27527911 |
| 36 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.25141258 |
| 37 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.24954882 |
| 38 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.24626161 |
| 39 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.23696924 |
| 40 | Retinol metabolism_Homo sapiens_hsa00830 | 1.23225199 |
| 41 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.20880182 |
| 42 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.20530742 |
| 43 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.20187946 |
| 44 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.20101340 |
| 45 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.16452400 |
| 46 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.16433233 |
| 47 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.15473657 |
| 48 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.11723888 |
| 49 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.11657777 |
| 50 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.10381613 |
| 51 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.08994088 |
| 52 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.08881542 |
| 53 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.06825868 |
| 54 | Lysine degradation_Homo sapiens_hsa00310 | 1.05306365 |
| 55 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.04565188 |
| 56 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.03548309 |
| 57 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.03238631 |
| 58 | Peroxisome_Homo sapiens_hsa04146 | 1.02737051 |
| 59 | Tuberculosis_Homo sapiens_hsa05152 | 1.02303260 |
| 60 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.02200942 |
| 61 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.01545264 |
| 62 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.94853107 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.93587179 |
| 64 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.92678913 |
| 65 | Malaria_Homo sapiens_hsa05144 | 0.91313750 |
| 66 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.90993559 |
| 67 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.90202775 |
| 68 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.89855989 |
| 69 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.89588098 |
| 70 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.89553944 |
| 71 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.89374729 |
| 72 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.87256812 |
| 73 | Influenza A_Homo sapiens_hsa05164 | 0.86705266 |
| 74 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.85303163 |
| 75 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.83967791 |
| 76 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.82669014 |
| 77 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.80619179 |
| 78 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.80206864 |
| 79 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.79781648 |
| 80 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.78691920 |
| 81 | Adherens junction_Homo sapiens_hsa04520 | 0.78646811 |
| 82 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.77969674 |
| 83 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.77549160 |
| 84 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.77312548 |
| 85 | Other glycan degradation_Homo sapiens_hsa00511 | 0.72851918 |
| 86 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.72661182 |
| 87 | Insulin resistance_Homo sapiens_hsa04931 | 0.72097180 |
| 88 | Legionellosis_Homo sapiens_hsa05134 | 0.68112208 |
| 89 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.66044139 |
| 90 | Galactose metabolism_Homo sapiens_hsa00052 | 0.65550385 |
| 91 | Measles_Homo sapiens_hsa05162 | 0.64680636 |
| 92 | Amoebiasis_Homo sapiens_hsa05146 | 0.61560409 |
| 93 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.61311693 |
| 94 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.60488772 |
| 95 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.58771434 |
| 96 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.58317430 |
| 97 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.56529762 |
| 98 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.56038856 |
| 99 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.55608982 |
| 100 | Phagosome_Homo sapiens_hsa04145 | 0.55547444 |
| 101 | Salmonella infection_Homo sapiens_hsa05132 | 0.55425125 |
| 102 | Bladder cancer_Homo sapiens_hsa05219 | 0.55171074 |
| 103 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.54647119 |
| 104 | Focal adhesion_Homo sapiens_hsa04510 | 0.52943831 |
| 105 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.52893857 |
| 106 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.52850097 |
| 107 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.52684723 |
| 108 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.52030749 |
| 109 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.51316817 |
| 110 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.50814971 |
| 111 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.50453609 |
| 112 | Apoptosis_Homo sapiens_hsa04210 | 0.50406941 |
| 113 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.50239213 |
| 114 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.49555012 |
| 115 | Shigellosis_Homo sapiens_hsa05131 | 0.49465820 |
| 116 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.49432449 |
| 117 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.48894258 |
| 118 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.48038484 |
| 119 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.47821393 |
| 120 | Hepatitis C_Homo sapiens_hsa05160 | 0.46603503 |
| 121 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.46286974 |
| 122 | Lysosome_Homo sapiens_hsa04142 | 0.46115962 |
| 123 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.45776753 |
| 124 | Carbon metabolism_Homo sapiens_hsa01200 | 0.45069923 |
| 125 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.44814546 |
| 126 | Viral myocarditis_Homo sapiens_hsa05416 | 0.42949350 |
| 127 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.42457071 |
| 128 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.40513201 |
| 129 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.40343478 |
| 130 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.39786769 |
| 131 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.38635413 |
| 132 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.36811224 |
| 133 | Leishmaniasis_Homo sapiens_hsa05140 | 0.36628802 |
| 134 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.36430629 |
| 135 | Phototransduction_Homo sapiens_hsa04744 | 0.36119039 |
| 136 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.35859246 |
| 137 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.35544909 |
| 138 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.34121029 |
| 139 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.34040771 |
| 140 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.32501768 |
| 141 | Pertussis_Homo sapiens_hsa05133 | 0.32143673 |
| 142 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.31729617 |
| 143 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.30881634 |
| 144 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.30232374 |

